184 related articles for article (PubMed ID: 8078682)
1. [Experimental rationale for the use of T-activin for correction of immunodeficiency in the treatment of periapical inflammation].
Volozhin AI; Arion VIa; Zyrianov GV; Krotova SB; Sysoeva OB
Patol Fiziol Eksp Ter; 1994; (2):19-20. PubMed ID: 8078682
[No Abstract] [Full Text] [Related]
2. [The use of taktivin in experimental apical periodontitis exacerbated by a secondary immunodeficiency state].
Zyrianov GV; Dmitrieva LA; Frolova TM; Belopol'skiĭ AA; Babaian SS
Stomatologiia (Mosk); 1993; 72(2):10-3. PubMed ID: 8048117
[TBL] [Abstract][Full Text] [Related]
3. [Principles of immunocorrective therapy using the thymus preparation T-activin].
Arion VIa; Ivanushkin EF
Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
[No Abstract] [Full Text] [Related]
4. Effect of T-activin on the course of experimental infection with Taenia crassiceps (Zeder, 1800) in mice.
Hermánek J; Prokopic J
Folia Parasitol (Praha); 1989; 36(2):117-26. PubMed ID: 2767556
[TBL] [Abstract][Full Text] [Related]
5. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
Iakhontova OI; Dudanova OP; Khavinson VKh
Sov Med; 1990; (6):85-8. PubMed ID: 2396134
[No Abstract] [Full Text] [Related]
6. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
Sov Med; 1990; (6):111-3. PubMed ID: 2144365
[No Abstract] [Full Text] [Related]
7. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
[No Abstract] [Full Text] [Related]
8. [The role of neutrophils in the pathogenesis of psoriasis and the effect of T-activin on them].
Korotkiĭ NG; Udzhukhu VIu; Vasil'eva LL; Redchenko EB; Bagandov TI
Vestn Dermatol Venerol; 1987; (7):19-22. PubMed ID: 3673241
[No Abstract] [Full Text] [Related]
9. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
Chukanov VI; Gergert VIa; Khomenko IS
Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
[TBL] [Abstract][Full Text] [Related]
10. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
[TBL] [Abstract][Full Text] [Related]
11. [The effect of thymic peptides on the development of streptozotocin-induced diabetes mellitus].
Novikov VI; Molotkov OV; Podcheko AP; Babichev AV
Patol Fiziol Eksp Ter; 1999; (3):25-8. PubMed ID: 10498991
[TBL] [Abstract][Full Text] [Related]
12. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
[No Abstract] [Full Text] [Related]
13. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
[TBL] [Abstract][Full Text] [Related]
14. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
[No Abstract] [Full Text] [Related]
15. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
Ianiushina VV
Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
[TBL] [Abstract][Full Text] [Related]
16. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
[TBL] [Abstract][Full Text] [Related]
17. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection.
Samsygin SA; Dolgina EN; Arion VYa ; Romanova LA; Shchevochkina GI; Ovchinnikova EA
J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):269-76. PubMed ID: 2809182
[TBL] [Abstract][Full Text] [Related]
18. [Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis].
Parnes EIa; Alikhanov BA; Tkomachev IuK; Muromtsev AV
Fiziol Cheloveka; 1995; 21(4):143-9. PubMed ID: 7589960
[No Abstract] [Full Text] [Related]
19. [Therapeutic and immunomodulating effects of T-activin in frequently ailing children with acute pneumonia].
Botvin'eva VV; Botvin'ev OK; Abdullaev AR; Gumbatov LD
Pediatriia; 1989; (10):107-8. PubMed ID: 2602057
[No Abstract] [Full Text] [Related]
20. [Use of T-activin in patients with sarcoidosis].
Romanov VV; Khomenko IS; Ozerova LV; Gergert VIa
Probl Tuberk; 1990; (4):15-7. PubMed ID: 2395843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
